drugset / Trial / NCT02818569

Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic

NCT02818569

Phase 1/2 Completed 15 enrolled Massachusetts General Hospital
RandomizedCrossoverTriple-blindTreatment

Summary

The broad objective of this investigation is to assess the safety and efficacy of oral therapy with dexmedetomidine for the induction and maintenance of restful sleep.

Timeline

Start
2016-10
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified Oral

Indications